Alberta Investment Management Corp Eagle Pharmaceuticals, Inc. Transaction History

Alberta Investment Management Corp

$10.2 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$17.74 - $31.87 $35,338 - $63,485	-1,992 Reduced 10.16%	17,606 $342,000
Q4 2022 Feb 14, 2023	SELL	$24.98 - $39.77 $21,507 - $34,241	-861 Reduced 4.21%	19,598 $572,000
Q3 2022 Nov 14, 2022	BUY	$26.42 - $47.12 $122,377 - $218,259	4,632 Added 29.27%	20,459 $541,000
Q1 2022 May 16, 2022	BUY	$44.58 - $52.6 $343,890 - $405,756	7,714 Added 95.08%	15,827 $783,000
Q4 2021 Feb 11, 2022	BUY	$45.82 - $56.9 $371,737 - $461,629	8,113 New	8,113 $413,000
Q3 2020 Oct 26, 2020	SELL	$37.02 - $51.28 $310,968 - $430,752	-8,400 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$43.24 - $55.02 $350,244 - $445,662	-8,100 Reduced 49.09%	8,400 $403,000
Q1 2020 May 08, 2020	SELL	$34.37 - $60.07 $214,812 - $375,437	-6,250 Reduced 27.47%	16,500 $759,000
Q4 2019 Feb 14, 2020	SELL	$54.32 - $64.31 $839,244 - $993,589	-15,450 Reduced 40.45%	22,750 $1.37 Million
Q3 2019 Oct 23, 2019	BUY	$53.25 - $59.98 $265,664 - $299,240	4,989 Added 15.02%	38,200 $2.16 Million
Q2 2019 Aug 14, 2019	BUY	$46.61 - $58.45 $415,341 - $520,847	8,911 Added 36.67%	33,211 $1.85 Million
Q1 2019 May 15, 2019	BUY	$38.66 - $51.82 $521,909 - $699,570	13,500 Added 125.0%	24,300 $1.23 Million
Q4 2018 Feb 14, 2019	SELL	$36.72 - $67.73 $190,944 - $352,196	-5,200 Reduced 32.5%	10,800 $435,000
Q3 2018 Nov 16, 2018	SELL	$66.65 - $83.86 $433,225 - $545,090	-6,500 Reduced 28.89%	16,000 $1.11 Million
Q2 2018 Aug 15, 2018	SELL	$51.25 - $76.62 $384,375 - $574,650	-7,500 Reduced 25.0%	22,500 $1.7 Million
Q1 2018 May 16, 2018	SELL	$52.16 - $66.86 $2.75 Million - $3.52 Million	-52,700 Reduced 63.72%	30,000 $1.58 Million
Q4 2017 Feb 15, 2018	BUY	$49.6 - $60.87 $1.33 Million - $1.63 Million	26,800 Added 47.94%	82,700 $4.42 Million
Q3 2017 Nov 14, 2017	BUY	$46.62 - $60.36 $2.61 Million - $3.37 Million	55,900	55,900 $3.33 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.

Account